Location History:
- Arezzo, IT (2010)
- Sesto Fiorentino, IT (2020)
Company Filing History:
Years Active: 2010-2020
Title: Marco Fragai: Innovator in Pharmaceutical Chemistry
Introduction
Marco Fragai is a notable inventor based in Sesto Fiorentino, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Fragai's work focuses on developing new therapeutic agents.
Latest Patents
Fragai's latest patents include the invention of aza-tanshinone derivatives, which are aimed at providing new methods for their preparation and therapeutic use. These derivatives are particularly promising as anti-tumor agents and anti-inflammatories. His second patent involves derivatives of arylsulfonamido-substituted hydroxamic acid, which serve as inhibitors of matrix metalloproteinases. These compounds exhibit good solubility in water and are useful in pharmaceutical compositions for treating diseases linked to metalloproteinase activity, as well as in cosmetic preparations for anti-aging purposes.
Career Highlights
Throughout his career, Marco Fragai has worked with esteemed institutions such as the University of Trento and Protera S.r.l. His research has significantly advanced the understanding and application of pharmaceutical compounds.
Collaborations
Fragai has collaborated with notable colleagues, including Claudio Luchinat and Alessandro Provenzani, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Marco Fragai's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work continues to influence therapeutic developments and offers promising solutions for various medical challenges.